A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Microfluidic assisted one-step fabrication of porous silicon@acetalated dextran nanocomposites for precisely controlled combination chemotherapy




TekijätLiu D., Zhang H., Mäkilä E., Fan J., Herranz-Blanco B., Wang C., Rosa R., Ribeiro A., Salonen J., Hirvonen J., Santos H.

KustantajaElsevier Ltd

Julkaisuvuosi2015

JournalBiomaterials

Tietokannassa oleva lehden nimiBiomaterials

Vuosikerta39

Aloitussivu249

Lopetussivu259

Sivujen määrä11

ISSN1878-5905

DOIhttps://doi.org/10.1016/j.biomaterials.2014.10.079

Verkko-osoitehttp://api.elsevier.com/content/abstract/scopus_id:84914133174


Tiivistelmä

An advanced nanocomposite consisting of an encapsulated porous silicon (PSi) nanoparticle and an acid-degradable acetalated dextran (AcDX) matrix (nano-in-nano), was efficiently fabricated by a one-step microfluidic self-assembly approach. The obtained nano-in-nano PSi@AcDX composites showed improved surface smoothness, homogeneous size distribution, and considerably enhanced cytocompatibility. Furthermore, multiple drugs with different physicochemical properties have been simultaneously loaded into the nanocomposites with a ratiometric control. The release kinetics of all the payloads was predominantly controlled by the decomposition rate of the outer AcDX matrix. To facilitate the intracellular drug delivery, a nona-arginine cell-penetrating peptide (CPP) was chemically conjugated onto the surface of the nanocomposites by oxime click chemistry. Taking advantage of the significantly improved cell uptake, the proliferation of two breast cancer cell lines was markedly inhibited by the CPP-functionalized multidrug-loaded nanocomposites. Overall, this nano-in-nano PSi@polymer composite prepared by the microfluidic self-assembly approach is a universal platform for nanoparticles encapsulation and precisely controlled combination chemotherapy.




Last updated on 2024-26-11 at 10:49